Successful Treatment of Condyloma Acuminata Using Office-Made Topical 60% Betel Leaf Extract

Reinecia Hidayat; Idrianti Idrus; Muhlis Yunus; Safruddin Amin; Anni Adriani; Muji Iswanty

doi:10.3889/oamjms.2022.8491

Authors

Reinecia Hidayat Department of Dermatology and Venereology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Idrianti Idrus Department of Dermatology and Venereology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Muhlis Yunus Department of Dermatology and Venereology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Safruddin Amin Department of Dermatology and Venereology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Anni Adriani Department of Dermatology and Venereology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Muji Iswanty Department of Dermatology and Venereology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.8491

Keywords:

Condyloma acuminata, Anogenital warts, Betel leaf

Abstract

BACKGROUND: Condyloma acuminata (CA), also known as anogenital warts, is a predominantly sexually transmitted disease caused by the Human Papillomavirus (HPV). The most common strains of HPV that causes anogenital warts are Type 6 and 11. This vdisease affects the mucous membrane as well as skin of the external genitalia and perianal areas. There are several therapeutic modalities for CA such as destructive and surgical therapies; however, these therapies can pose side-effects mostly tissue destruction. Alternative modalities such as using betel leaf can be atreatment option for CA.

CASE REPORT: In this paper, we report a 31-year-old female with CA who experienced clinical improvement after 3 weeks of office-made 60% topical betel leaf extract therapy, prompting more thorough research on the possible use of herbal treatments for treating CA.

CONCLUSION: Office-made betel leaf extract therapy is a promising topical therapy for CA and is relatively simple to prepare. The plant has various mechanisms such as anti-proliferative and cytotoxic properties that can be studied further to prove its efficacy in the treatment of CA to prevent adverse events caused by other conventional destructive treatment modalities.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Bolan GA. Human papillomavirus infection. In: Rasmussen SA, Rutledge TF, Johnson DC, Wilson RJ, editors. Sexually Transmitted Diseases Treatment Guidelines. United States: Department of Health and Human Services: Centers for Disease Control and Prevention; 2015. p. 84-90.

Hum M, Chow E, Schuurmans N, Dytoc M. Case of giant vulvar condyloma acuminata successfully treated with imiquimod 3.75% cream: A case report. SAGE Open Med Case Rep. 2018;6:2050313X18802143. https://doi.org/10.1177/2050313X18802143 PMid:30345054 DOI: https://doi.org/10.1177/2050313X18802143

Léonard B, Kridelka F, Delbecque K, Goffin F, Demoulin S, Doyen J, et al. A clinical and pathological overview of vulvar condyloma acuminatum, intraepithelial neoplasia, and squamous cell carcinoma. Biomed Res Int. 2014;2014:480573. https://doi.org/10.1155/2014/480573 PMid:24719870 DOI: https://doi.org/10.1155/2014/480573

O’Mahony C, Gomberg M, Skerlev M, Alraddadi A, de las Heras-Alonso M, Majewski S, et al. Position statement for the diagnosis and management of anogenital warts. J Eur Acad Dermatol Venereol. 2019;33(6):1006-19. https://doi.org/10.1111/jdv.15570 PMid:30968980 DOI: https://doi.org/10.1111/jdv.15570

Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14-26. https://doi.org/10.1016/j.bpobgyn.2017.08.006 PMid:29037457 DOI: https://doi.org/10.1016/j.bpobgyn.2017.08.006

Yuan J, Ni G, Wang T, Mounsey K, Cavezza S, Pan X, et al. Genital warts treatment: Beyond imiquimod. Hum Vaccin Immunother. 2018;14(7):1815-9. https://doi.org/10.1080/21645 515.2018.1445947 PMid:29505317 DOI: https://doi.org/10.1080/21645515.2018.1445947

Hamka A, Fatimawali F, Datu OS, Tallei TE. Antibacterial activity of betel (Piper betle L.) fruit against Pseudomonas aeruginosa. Acta Biochim Indones. 2021;4(1):10. DOI: https://doi.org/10.32889/actabioina.10

Ugurlucan FG, Yasa C, Demir O, Dural O, Yavuz E, Akhan SE. Giant vulvar condylomata: Two cases and a review of the literature. Case Rep Obstet Gynecol. 2019;2019:1470105. https://doi.org/10.1155/2019/1470105 PMid:31223511 DOI: https://doi.org/10.1155/2019/1470105

Leslie SW, Sajjad H, Kumar S. Genital Warts. Treasure Island, FL: StatPearls; 2021.

James WD. Viral diseases. In: Gabbedy R, Lowson K, editors. Diseases Andrews’ of the Skin. 11th ed. United States: Saunders, Elsevier; 2011. p. 401-4.

Sterling JC. Human papillomavirus infection. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, editors. Fitzpatrick’’s Dermatology. 9th ed. United States: McGraw Hill Education; 2019. p. p. 3095-106.

Shah SK, Garg G, Jhade D, Patel N. Piper betle: Phytochemical, pharmacological and nutritional value in health management. Int J Pharm Sci Rev Res. 2016;38(2):181-9.

Madhumita M, Guha P, Nag A. Bio-actives of betel leaf (Piper betle L.): A comprehensive review on extraction, isolation, characterization, and biological activity. Phytother Res. 2020;34(10):2609-27. https://doi.org/10.1002/ptr.6715 PMid:32524688 DOI: https://doi.org/10.1002/ptr.6715

Rekha V, Kollipara M, Gupta B, Bharath Y, Pulicherla KK. A review on Piper betle L.: Nature’s promising medicinal reservoir. Am J Ethnomed. 2014;1(5):276-89.

Jayalakshmi B, Raveesha K, Murali M, Amruthesh K. Phytochemical, antibacterial and antioxidant studies on leaf extracts of Piper betle L. Int J Pharm Pharm Sci. 2015;7(10):23-9.

Dwivedi V, Tripathi S. Review study on potential activity of Piper betle. J Pharmacogn Phytochem. 2014;3(4):93-8.